<!DOCTYPE html>
<html lang="en" dir="ltr"><head>
  
                           
     


<meta charset="UTF-8">
<meta http-equiv="X-UA-Compatible" content="IE=edge,chrome=1">
<meta name="viewport" content="width=device-width, initial-scale=1, shrink-to-fit=no">
<meta name="generator" content="Hugo 0.85.0" />
<title>Germline and somatic mutations of multi-gene panel in Chinese patients with epithelial ovarian cancer | Personal website of Di Shao</title>


<meta property="twitter:site" content="@apreshill">
<meta property="twitter:creator" content="@apreshill">







  
    
  
<meta name="description" content="通过分析入组人群的遗传易感21基因的胚系和体系突变位点特征，绘制中国人群上皮性卵巢癌遗传易感基因胚系和体系突变图谱，推动卵巢癌的精准治疗和精准预防。">


<meta property="og:site_name" content="Personal website of Di Shao">
<meta property="og:title" content="Germline and somatic mutations of multi-gene panel in Chinese patients with epithelial ovarian cancer | Personal website of Di Shao">
<meta property="og:description" content="通过分析入组人群的遗传易感21基因的胚系和体系突变位点特征，绘制中国人群上皮性卵巢癌遗传易感基因胚系和体系突变图谱，推动卵巢癌的精准治疗和精准预防。" />
<meta property="og:type" content="page" />
<meta property="og:url" content="https://dishao.netlify.app/project/ovarian_cancer/" />
<meta property="og:locale" content="en">




    
        <meta property="og:image" content="https://dishao.netlify.app/project/ovarian_cancer/featured.png" >
        <meta property="twitter:card" content="summary_large_image">
        <meta name="twitter:image" content="https://dishao.netlify.app/project/ovarian_cancer/featured.png" >
    
    
  <meta itemprop="name" content="Germline and somatic mutations of multi-gene panel in Chinese patients with epithelial ovarian cancer">
<meta itemprop="description" content="Background
Multiple targeted gene sequencing is seldom performed in both germline and somatic testing for ovarian cancer. This study is to evaluate the specific genetic alterations, including both somatic and germline mutations, in Chinese patients with epithelial ovarian cancer (EOC) in a prospective cohort study.
Materials and methods
Mutations in a customed 21-gene panel that included BRCA1 , BRCA2 , and 19 other tumor suppressor genes related to homologous recombination (HR) deficiency or non-HR deficiency were detected by targeted exon capture and next-generation sequencing (NGS) technology across all coding exons and exon-intron (±20 base pairs) boundaries.">

<meta itemprop="wordCount" content="312"><meta itemprop="image" content="https://dishao.netlify.app/project/ovarian_cancer/featured.png">
<meta itemprop="keywords" content="ovarian_cancer," />
  
  <!--[if IE]><script src="//html5shiv.googlecode.com/svn/trunk/html5.js"></script><![endif]-->
  <link rel="shortcut icon" href="/img/icons8-cancer-64.png" type="image/x-icon">
  <link rel="icon" href="/img/icons8-cancer-64.png" type="image/x-icon">
  
  
  <link rel="stylesheet" href="/style.main.min.c41989e55e447ba851529faee9089cf175da56ad7aa754b67d2288a69ba974e6.css" integrity="sha256-xBmJ5V5Ee6hRUp&#43;u6Qic8XXaVq16p1S2fSKIppupdOY=" media="screen">
  
  
  <script src="/panelset.min.078a92db9bd3228df502db3d9e0453c3cf3d910abe3f8deca0ad196c7071ad41.js" type="text/javascript"></script>
  
  
  <script src="/main.min.38a0323c5b0bbb611c4874ba2d8fdaba57d20cc2b0d704b30250c235ba8b6d49.js" type="text/javascript"></script>
</head>
<body>
      <div class="grid-container single">
<header class="site-header pt4 pb2 mb4 bb b--transparent ph5 headroom z-max" role="banner">
  <nav class="site-nav db dt-l w-100" role="navigation">
    <a class="site-brand db dtc-l v-mid link no-underline w-100 w-33-l tc tl-l" href="https://dishao.netlify.app" title="Home">
      <img src="/img/6745552_preview.png" class="dib db-l h2 w-auto" alt="Personal website of Di Shao">
    </a>
    <div class="site-links db dtc-l v-mid w-100 w-47-l tc tr-l mt3 mt0-l ttu tracked">
      
        
        
        
      <a class="link f6 f5-l dib pv1 ph2 " href="/about/" title="About Me">About</a>
      
        
        
        
      <a class="link f6 f5-l dib pv1 ph2 " href="/blog/" title="Blog">Blog</a>
      
        
        
        
      <a class="link f6 f5-l dib pv1 ph2 active" href="/project/" title="Project Portfolio">Projects</a>
      
        
        
        
      <a class="link f6 f5-l dib pv1 ph2 " href="/talk/" title="Talks">Talks</a>
      
        
        
        
      <a class="link f6 f5-l dib pv1 ph2 " href="/cv/" title="CV">CV</a>
      
      
    </div>
  </nav>
</header>

<main class="page-main pa4" role="main">
  <section class="page-content mw7 center">
    <article class="post-content pa0 ph4-l">
      <header class="post-header">
        <h1 class="f1 lh-solid measure-narrow mb3 fw4">Germline and somatic mutations of multi-gene panel in Chinese patients with epithelial ovarian cancer</h1>
        
        
        <p class="f7 db mv0 ttu">January 1, 0001</p>

      
      <div class="ph0 pt5">
        
    
    
    
      
    
    
    
    
    
      
      
  <a class="btn-links mr2 ba dib" href="https://www.frontiersin.org/articles/10.3389/fonc.2021.630717/full" target="_blank" rel="noopener"><i class="far fa-newspaper fa-lg fa-fw mr2"></i>Full article</a>


      </div>
      

      </header>
      <section class="post-body pt5 pb4">
        <p><img src="fig0.png" alt="">
<strong>Background</strong></p>
<p>Multiple targeted gene sequencing is seldom performed in both germline and somatic testing for ovarian cancer. This study is to evaluate the specific genetic alterations, including both somatic and germline mutations, in Chinese patients with epithelial ovarian cancer (EOC) in a prospective cohort study.</p>
<p><strong>Materials and methods</strong></p>
<p>Mutations in a customed 21-gene panel that included BRCA1 , BRCA2 , and 19 other tumor suppressor genes related to homologous recombination (HR) deficiency or non-HR deficiency were detected by targeted exon capture and next-generation sequencing (NGS) technology across all coding exons and exon-intron (±20 base pairs) boundaries. Patients were enrolled consecutively and unselectively without age or family history consideration. Sixty-two unselected patients with epithelial ovarian cancer were enrolled in our study to be tested for paired somatic and germline mutations. All patients were tested using a 21-gene panel that included BRCA1 , BRCA2 , CHEK2 , PALB2 , BRIP1 , TP53 , PTEN , STK11 , CDH1 , ATM , BARD1 , MLH1 , MRE11A , MSH2 , MSH6 , MUTYH , NBN , PMS1 , PMS2 , RAD50 , and RAD51C .</p>
<p><strong>Results</strong></p>
<p>Mutation analysis revealed that 77.4% (48/62) of patients carried one or more of 64 identified genetic alterations, including 19 germline and 45 somatic deleterious mutations. Twelve individuals shared both germline and somatic mutations. BRCA mutants existed in 17 of 62 (27.4%) patients. Of the 64 mutations detected, 46 (74.2%) were in 7 other HR or non-HR genes, including TP53 , PTEN , ATM , CHEK2 , PALB2 , RAD51C , and STK11 . In somatic mutation analysis, TP53 showed frequent pathogenic or likely pathogenic mutations in 56.5% (35/62) of enrolled cases, among which six cases harbored a loss of heterozygosity.</p>
<p><strong>Conclusions</strong></p>
<p>This is the first report of multi-gene panel testing for germline and somatic mutations among Chinese EOC patients, which revealed a broader deleterious variants than only BRCA testing.</p>
<p><img src="fig1.png" alt=""></p>

        
        <details closed class="f6 fw7 input-reset">
  <dl class="f6 lh-copy">
    <dt class="fw7">Posted on:</dt>
    <dd class="fw5 ml0">January 1, 0001</dd>
  </dl>
  <dl class="f6 lh-copy">
    <dt class="fw7">Length:</dt>
    <dd class="fw5 ml0">2 minute read, 312 words</dd>
  </dl>
  
  <dl class="f6 lh-copy">
    <dt class="fw7">Categories:</dt>
    <dd class="fw5 ml0"> <a href="https://dishao.netlify.app/categories/ovarian-cancer">ovarian cancer,</a>  <a href="https://dishao.netlify.app/categories/parpi">parpi,</a>  <a href="https://dishao.netlify.app/categories/precise-treatment">precise treatment</a> </dd>
  </dl>
  
  
  
  <dl class="f6 lh-copy">
    <dt class="fw7">Tags:</dt>
    <dd class="fw5 ml0"> <a href="https://dishao.netlify.app/tags/ovarian_cancer">ovarian_cancer</a> </dd>
  </dl>
  
  <dl class="f6 lh-copy">
    <dt class="fw7">See Also:</dt>
    
  </dl>
</details>

      </section>
      <footer class="post-footer">
        <div class="post-pagination dt w-100 mt4 mb2">
  
  
    <a class="prev dtc pr2 tl v-top fw6"
    href="https://dishao.netlify.app/project/cpg_method/">&larr; A targeted next-generation sequencing method for identifying clinically relevant mutation profiles in lung adenocarcinoma</a>
  
  
  
    <a class="next dtc pl2 tr v-top fw6"
    href="https://dishao.netlify.app/project/hrd/">Homologous recombination deficiency status predicts response to platinum‑based chemotherapy in Chinese patients with high‑grade serous ovarian carcinoma &rarr;</a>
  
</div>

      </footer>
    </article>
    
  </section>
</main>
<footer class="site-footer pv4 bt b--transparent ph5" role="contentinfo">
  <nav class="db dt-l w-100">
    <p class="site-copyright f7 db dtc-l v-mid w-100 w-33-l tc tl-l pv2 pv0-l mv0 lh-copy">
      &copy; 2023 Di Shao, Shenzhen
      <span class="middot-divider"></span>
      Made with <span xmlns:dct="http://purl.org/dc/terms/" property="dct:title"><a xmlns:dct="http://purl.org/dc/terms/" href="https://github.com/hugo-apero/" rel="dct:source">Hugo Apéro</a></span>.
      <br />
      
Based on <span xmlns:dct="http://purl.org/dc/terms/" property="dct:title"><a xmlns:dct="http://purl.org/dc/terms/" href="https://github.com/formspree/blogophonic-hugo" rel="dct:source">Blogophonic</a></span> by <a xmlns:cc="http://creativecommons.org/ns#" href="https://formspree.io" property="cc:attributionName" rel="cc:attributionURL">Formspree</a>.
    </p>
    
    <div class="site-social-links db dtc-l v-mid w-100 w-33-l tc pv2 pv0-l mv0">
      <div class="social-icon-links" aria-hidden="true">
  
  
    
    
    
      
    
    
    
    
    
      
    
    <a class="link dib h1 w1 ml0 mr2 f6 o-90 glow" href="https://www.jianguoyun.com/p/DX1SvlkQ98bmBRjO6pcE" title="weixin" target="_blank" rel="noopener">
      <i class="fab fa-weixin fa-lg fa-fw"></i>
    </a>
  
    
    
    
      
    
    
    
    
    
      
    
    <a class="link dib h1 w1 ml0 mr2 f6 o-90 glow" href="https://www.linkedin.com/in/%E8%BF%AA-%E9%82%B5-0a68259a/" title="linkedin" target="_blank" rel="noopener">
      <i class="fab fa-linkedin fa-lg fa-fw"></i>
    </a>
  
    
    
    
    
    
    
    
      
    
    <a class="link dib h1 w1 ml0 mr2 f6 o-90 glow" href="https://orcid.org/0000-0002-1485-2074" title="orcid" target="_blank" rel="noopener">
      <i class="ai ai-orcid fa-lg fa-fw"></i>
    </a>
  
    
    
    
      
    
    
    
    
    
      
    
    <a class="link dib h1 w1 ml0 mr2 f6 o-90 glow" href="https://github.com/Di-Shao" title="github" target="_blank" rel="noopener">
      <i class="fab fa-github fa-lg fa-fw"></i>
    </a>
  
    
    
    
      
    
    
    
    
    
      
    
    <a class="link dib h1 w1 ml0 mr2 f6 o-90 glow" href="/blog/index.xml" title="rss" >
      <i class="fas fa-rss fa-lg fa-fw"></i>
    </a>
  
</div>

    </div>
    
    <div class="site-links f6 db dtc-l v-mid w-100 w-67-l tc tr-l pv2 pv0-l mv0">
      
      <a class="dib pv1 ph2 link" href="/license/" title="License">License</a>
      
      <a class="dib pv1 ph2 link" href="/contact/" title="Contact form">Contact</a>
      
    </div>
  </nav>
</footer>

      </div>
    </body>
</html>
